This transcriptional activity is associated with the bromodomain-containing factor BRD4, which also binds to acetylated lysine-310 of the subunit RelA (p65) of the activity of transcription factor NFκB, maintaining persistently active NFκB in malignant tumors [6]. Here, NFKB1 is linked to cancer.